Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

The CBSE Class 10 English Board Exam is scheduled for February 21, 2026. As it is an important milestone in every student’s academic journey, the marks scored in this examination significantly ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

Dear Dr. Roach: I am a 68-year-old male in good health who exercises regularly, doesn't take any medications, and doesn't have a family history of prostate cancer. During my most recent yearly ...

The 23-year ERSPC trial reveals that sustained, protocolized PSA testing lowers prostate cancer deaths and improves the benefit-to-harm ratio, supporting a shift toward risk-based, patient-centered ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...